Quidel’s COVID-19 Test Receives Emergency Use Authorization

Quidel has received a new EUA from the FDA for its Lyra Direct SARS-CoV-2 assay.

The updated test replaces upfront RNA sample extraction with a 10-minute heat step to cut processing time by up to 50 minutes.

The assay can run on polymerase chain reaction machines made by Applied Biosystems, Bio-Rad, Qiagen, Roche and Thermo Fisher.